Document is current
Any future updates will be listed below
-
Authors
Kong, Ziren
Li, Zhu
Chen, Junyi
Shi, Yixin
Li, Nan
Ma, Wenbin
Wang, Yu
Yang, Zhi
Liu, Zhibo http://orcid.org/0000-0002-5587-4165
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Beijing Municipality (Z200018, 7232351)
National Natural Science Foundation of China (22225603, 32301152)
Ministry of Science and Technology of the People's Republic of China (2021YFA1601400)
Peking University (PY202309)
- License Information
-
More Information
Article History
Received: 11 December 2023
Accepted: 22 January 2024
First Online: 2 February 2024
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of the Peking University Cancer Hospital (ID 2021KT38), and written informed consent was obtained from all participants.
: Not applicable.
: ZLiu is the consultant of Boomray Pharmaceuticals (Beijing) Co., Ltd.; other authors reported no conflict of interest.
